The Offer Is $1.02. The Stock Closed Higher.
Advent International wants to take Definitive Healthcare private for $1.02 a share — and the company's founder is aligned with the buyer, not with the public shareholders.
Venue
nasdaq
Exchange-listed, but small. These companies file with the SEC — and have to hold on to their listing.
Stories
140
Updated
21 Sep
More on Nasdaq
An Antibody That Fights Tumors Three Ways Just Got a U.S. Patent Nod
A Real Estate Company Now Wants to Build an AI Data Centre in Europe
Revenue Up Twentyfold. Still Losing More Than It Makes.
NIO's Margins Nearly Doubled. The Stock Fell Anyway.
An Automotive Lidar Maker Just Won a Contract to Navigate the Moon
The CEO Just Bought Nearly Half Her Company in a Single Private Deal
The Action Camera Brand Is Becoming an AI Optics Company
A Former Solar-Car Startup Is Merging Into a Sports Franchise Fund
AIM ImmunoTech Gets Patent Pairing Its Cancer Drug With Keytruda
A Rare Earth Magnet Maker Is Sextupling Its Power Supply in Korea
Ten Straight Quarters, and So-Young's Losses Are Shrinking
Investors Gave Up the Right to Buy Shares. They Got Nothing Back.
RedHill Sells Its H. Pylori Drug to Fund Its Next Move
Antelope Cut Its Share Count. Then It Sold More Shares Than It Had Left
BioXcel Is Bankrupt. Teva Is First in Line for IGALMI.